The following two MHRA guidance notes have been updated:

These guidance notes have been updated following the consolidation of medicines legislation into the Human Medicines Regulations 2012 and the implementation of the Falsified Medicines Directive.

These guidance notes have been published to help applicants and those who hold a manufacturer’s licence, wholesale dealer’s licence (WDA(H)) or broker registration. They outline the key obligations for maintaining the licence/registration.  

 

Posted on the UK MHRA website on 4 July 2014